JADRAN GALENSKI LABARATORIJ
JGL was founded in 1991 as the first completely private pharmaceutical joint stock company in Croatia.
Since the early days, it was believed that over time it would develop into an international pharmaceutical company that would operate outside Croatian borders. With entrepreneurship, ambition and great passion and energy, it was a start of a story that has lasted more than a quarter of a century. It was crucial to gather and motivate people, to create a team ready for great challenges.
The story of JGL’s success gained momentum when JGL left the “Jadran” pharmacy, just after the collapse of Yugoslavia, and with the start of generic drugs production in the category of essential drugs. These were drugs of small production series that were not interesting to the large pharmaceutical industry because they were not profitable.
By leaving the local frameworks and expanding the business in the territory of Croatia, and then the region – to Slovenia in 1992, Bosnia and Herzegovina in 1997 and to Macedonia and Serbia in 2001 – an additional step was taken that created the preconditions for further growth and development. Nevertheless, the launch of operations in the markets of Russia (1998), followed by Ukraine (2004) and Kazakhstan (2006), from the current perspective, has proved to be a key strategic decision for the company.
Showing 1 to 10 of 10 (1 Pages)